Skip to main content
. 2020 Jun 12;11(6):455. doi: 10.1038/s41419-020-2648-0

Table 1.

The sequences.

Name Sequence
miR-450b-5p forward CGCGTTTTGCAGTATGTTCC
miR-450b-5p reverse AGTGCAGGGTCCGAGGTATT
U6 forward AGAGAAGATTAGCATGGCCCCTG
U6 reverse ATCCAGTGCAGGGTCCGAGG
CRYAB forward GAGTCTGACCTCTTCTCAACAG
CRYAB reverse AGAACCTTGACTTTGAGTTCCT
CD206 forward GGAATCAAGGGCACAGAGTTA
CD206 reverse ATTGTGGAGCAGATGGAA
TNF-α forward TATGGCTCAGGGTCCAACTC
TNF-α reverse GGAAAGCCCATTTGAGTCCT
Arg-1 forward CTGCCTGCTTTCTGAGTGCTGAG
Arg-1 reverse CCTGTGGTTCCGATAAGTGCTTCC
TGF-β1 forward AGGGCTACCATGCCAACTTC
TGF-β1 reverse CCACGTAGTAGACGATGGGC
β-actin forward GGCTGTATTCCCCTCCATCG
β-actin reverse CCAGTTGGTAACAATGCCATGT
miR-450b-5p mimic forward UUUUGCAGUAUGUUCCUGAAUA
miR-450b-5p mimic reverse UUCAGGAACAUACUGCAAAAUU
miR-450b-5p inhibitors UAUUCAGGAACAUACUGCAAAA
miR-450b-5p antagomir UAUUCAGGAACAUACUGCAAAA
CRYAB shRNA (target sequence) GGAACTCAAAGTCAAGGTTCT